Neurosurgery Nomogram

Unlock advanced neuro-oncology analytics with this clinical-grade prognostic tool. Powered by extensive data from the Surveillance, Epidemiology, and End Results (SEER) Program (2000–2023), the app delivers robust, tumor-specific nomogram models to predict individualized survival outcomes at user-defined timepoints from 0 to 120 months. Designed for seamless clinical and research navigation, the application translates complex epidemiological data into interactive, visual insights across a wide spectrum of central nervous system and brain tumors. Tumor Types: Astrocytoma, Ependymoma, Esthesioneuroblastoma, Glioma, Glioblastoma, Medulloblastoma, Meningioma, Oligodendroglioma, Pilocytic Astrocytoma, Pleomorphic Xanthoastrocytoma, Posterior Fossa Glioblastoma and Schwannoma. Rigorous Statistical Testing Internal Validation: 500-sample bootstrapping built with optimism-corrected calibration. External Validation: Temporal validation utilizing an 80% training and 20% testing cohort split. Interactive Workspace Tabs Kaplan-Meier Curves: Survival analysis. Forest Plot: Hazard ratio and variable visualization. Treatment Comparison: Evaluate multi-modal therapeutic strategies. Calibration, Discrimination & Validation Metrics: Verify model accuracy in real-time.